The points you raise about resources required to support administration of these therapies is a good one and I do agree with it. It's why my wife ultimately did not get IVC, I found an alternative care doc to administer it but didn't trust his ability to actually do it safely. There's generally a resource shortage all around, maybe especially with the oncology docs themselves. I think we had 20-24 hours in front of her doc through her two year treatment, 8 in surgery and the rest peppered through infusion visits and inpatient.

I'm pretty confident IVC will end up at least as part of palliative care. Nobody is going to fund trials for it for adjunct cancer therapy because onc docs want to see trials for their specific cancer and given it's not even a candidate for monotherapy it's just not going to get the investment.